O'Neill Institute

O'Neill Institute

@oneillinstitute

Followers4.6K
Following1.1K

Innovative legal and policy solutions to the world's most pressing health concerns. Leading legal analysis on #COVID19 #Coronavirus. Based @GeorgetownLaw

Georgetown Law, Washington, DC
Joined on September 09, 2013
Statistics

We looked inside some of the tweets by @oneillinstitute and here's what we found interesting.

Inside 100 Tweets

Time between tweets:
3 hours
Average replies
1
Average retweets
6
Average likes
15
Tweets with photos
22 / 100
Tweets with videos
0 / 100
Tweets with links
0 / 100

More health experts and advocates have called for the decriminalization of sex work. @usnews noted @seanbland8 and @nottweetingben’s findings of the various health challenges sex workers face. https://t.co/8TTfewUZeI

“It will be enormously damaging to public trust in the vaccine if President Trump isn't visibly enthusiastic, including getting his shot on national television. It simply isn't good enough to have Vice President Pence as a proxy,” noted @LawrenceGostin. https://t.co/qNnKjL0yqB

“More than any law or regulation, investment or intervention, national policy or global strategy, global health security requires a new politics,” write @LawrenceGostin and Sarah Wetter on what lessons to learn from #COVID19. https://t.co/XI3qPkeAYw

It's always fun to collaborate w/@oneillinstitute and Harrison Institute colleagues to teach the @GeorgetownLaw Week One simulation of int'l climate and health negotiations! Inspired and impressed with all the great work & creativity of our 1L students! https://t.co/9uCRhkts9Z

It's always fun to collaborate w/@oneillinstitute and Harrison Institute colleagues to teach the @GeorgetownLaw Week One simulation of int'l climate and health negotiations! Inspired and impressed with all the great work & creativity of our 1L students! https://t.co/9uCRhkts9Z

Interested in law fellowship opportunities? Applications are open for our Post-Graduate Fellowship, which is intended to expose Fellows to different areas, including health and human rights and global health governance. The deadline to apply is Jan. 22. https://t.co/xnImxi6Gv5

Quoted @oneillinstitute

The success of the #COVID19 vaccination campaign in India depends on public trust and efficacy of the vaccines. However, the current lack of transparency will have domestic and international ramifications, writes @KashishAneja_ in the latest Expert Column. https://t.co/TBtjKrdkmu

The success of the world's largest immunization program depends on public trust! Transparency deficit will have domestic and international ramifications. I write for the @oneillinstitute expert column. https://t.co/23xgLOkHO5

The success of the #COVID19 vaccination campaign in India depends on public trust and efficacy of the vaccines. However, the current lack of transparency will have domestic and international ramifications, writes @KashishAneja_ in the latest Expert Column. https://t.co/TBtjKrdkmu

Quoted @GPPi

📽️ While the COVID-19 vaccine rollout is well underway, there are major challenges to implementation. How can governments rise to the task? Watch #GGF2035 alumni explain the ripple effects of vaccination programming & what fair access could look like: https://t.co/g4KNxVWIfX https://t.co/YRt33AWFvi

📽️ While the COVID-19 vaccine rollout is well underway, there are major challenges to implementation. How can governments rise to the task?

Watch #GGF2035 alumni explain the ripple effects of vaccination programming & what fair access could look like: https://t.co/g4KNxVWIfX https://t.co/YRt33AWFvi

How can we address the challenges to the #COVID19 vaccine rollout? @mplngr answered this question in an online discussion with @GPPi: https://t.co/7Utc2LrJ4a

ICYMI: @LawrenceGostin and @MMKavanagh joined #AskReuters yesterday to answer critical questions on #COVID19 vaccines. Read what they and other health experts said: https://t.co/GxABvGqTSv

Tomorrow, @mplngr will be joining @fairfaxlibrary for their next "Great Decisions" discussion. Hear from her on the role of international organizations in a global pandemic. Register here: https://t.co/vs4iwJdOov

Excited to be moderating this important session on #HIV retention for civil society leaders in 15m with @MBKeno of @hepsuganda,  Anna Grimsrud @iasociety, @milangamaureen of @HealthGAP 
#PEPFARWatch https://t.co/wMaZktsGAn

Excited to be moderating this important session on #HIV retention for civil society leaders in 15m with @MBKeno of @hepsuganda, Anna Grimsrud @iasociety, @milangamaureen of @HealthGAP #PEPFARWatch https://t.co/wMaZktsGAn

Reuters
3 days ago
'We are not safe until the entire world is safe': Experts discuss the promises and challenges of the global vaccine rollout #AskReuters https://t.co/o4aOATun5w https://t.co/i8JfuozgRt

'We are not safe until the entire world is safe': Experts discuss the promises and challenges of the global vaccine rollout #AskReuters https://t.co/o4aOATun5w https://t.co/i8JfuozgRt

Quoted @onufreyonboard

Why do we need a second dose of the vaccine after we had a dose? #AskReuters

We need a 2nd vaccine dose b/c the first dose "primes" the immune system. The 2nd dose confers additional protection. FDA says 2 mRNA vaccines confer 95% efficacy. But that assumes 2 doses. https://t.co/vmYOEjiwkI

Quoted @Alistair_SBD

@Reuters Good evening. What do you make of plans to stretch out the interval between the first and second shots in some countries, #AskReuters? What does the evidence say? Thank you.

The UK & others are extending the interval between doses so they can more quickly protect the pop. While 1 dose confers a lot of protection, clinical trials were designed w/ 2 doses as set intervals. We should stick to the science. If we deviate from science too far, we add risk https://t.co/2Zn349Majr

A9. #AskReuters What gives me hope is the power of science and human ingenuity. Up until now we were no match for the coronavirus. But we now have vaccines in record time. We hope this will bring a healthy new year to the US and ALL OF HUMANITY. That's what gives me hope now.

A7. We are obsessed w/ vaccination in the US, but we also need to be fair to all our global citizens. @WHO Covax aims to get vaccines to 20% of pop in low income countries, but that's not enough. US & others are hoarding vaccines. Vaccine nationalism is unethical. #AskReuters

A6. Herd immunity is achieved when a large part of the pop has been vaccinated or had COVID. It'll take time even in the US. It won't happen until late 2021 or even 2022. If we can vaccinate say 70% of US pop we can achieve herd immunity. Let's end pandemic this year #AskReuters

A9. The #PeoplesVaccine campaign gives me hope. People around the world are coming together to ask their governments to act responsibly and in all of our interests by making vaccine technology open to all. 
 #AskReuters  @Winnie_Byanyima 
https://t.co/n8jcu55UoA https://t.co/GcBXEclpvt https://t.co/YvLZ4t3cFx

A9. The #PeoplesVaccine campaign gives me hope. People around the world are coming together to ask their governments to act responsibly and in all of our interests by making vaccine technology open to all. #AskReuters @Winnie_Byanyima https://t.co/n8jcu55UoA https://t.co/GcBXEclpvt https://t.co/YvLZ4t3cFx

Next Page